Precision medicine testing for advanced, hard-to-remove cancers
Part of Cancer clinical trials.
This study helps doctors use more individualized (precision) treatment choices for people with certain advanced cancers. You may be offered study care based on your cancer details, aiming to improve treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- You have a solid (non-blood) cancer tumor
- Your cancer is advanced and cannot be removed with surgery and/or has spread, with specific matching situations for prostate or certain breast cancers
- You can do daily activities fairly well (ECOG less than 2, meaning not very limited)
- There must be measurable cancer on scans (measurable disease)
- You can legally join in France and sign informed consent before any study steps
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether choosing cancer treatments based on the unique genetic changes in your tumor can help people with advanced cancer live longer. You would receive FDA-approved drugs that match your tumor's specific markers.
This study tests different treatments tailored to your cancer's biology. It aims to find which therapy might work best for you, potentially improving outcomes. You'd receive one of the study drugs, with close monitoring and support.
This trial is studying a special type of cell that shows up in the blood of people with certain advanced cancers. It aims to find out if these cells can help doctors better understand the cancer and guide treatment.
This study compares different methods of capturing circulating tumor cells (CTCs) from blood samples in patients with metastatic breast or prostate cancer. It aims to improve how we detect and monitor cancer cells that have spread, which could help guide future treatment decisions.
This study helps doctors better understand your cancer by doing tumor/cancer profiling as part of research. If you qualify, your participation may help improve how cancers are studied and matched with future treatments.
This study uses advanced DNA testing on tumor samples to help match cancer treatments more precisely. It may help researchers learn which cancer changes are driving your tumor and how they relate to treatment choices.
Hear when a new Metastatic Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.